"环胺和类似物;双重抗癌作用的剂量和时间表问题"
Julia Delahousse1, Leonardo Molina1, Angelo Paci2
1Gustave Roussy, Department of Pharmacology, Villejuif, France.
Cancer letters
|July 13, 2024
概括
用环胺 (CPM) 进行的计量化学疗法为癌症治疗提供了一种更安全,双重作用的方法. 这种免疫活性策略在各种癌症中表现有前途,有可能提高治疗效率和安全性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 传统化疗使用最大耐受剂量,往往导致显著的毒性.
- 化剂如环胺 (CPM) 和ifosfamide由于毒性而具有治疗限制.
- 计量化学疗法通过使用最小有效剂量提供了一个潜在的更安全的替代方案.
研究的目的:
- 为了探索循环胺在计量剂量中的双重抗瘤机制.
- 为了评估计量学循环胺在各种癌症类型中的疗效和安全性.
- 评估计量学CPM作为标准癌症治疗的潜力,单独或结合治疗.
主要方法:
- 对临床研究的综述,研究了在癌症治疗中计量型环胺 (CPM) 的作用.
- 在高剂量和计量剂量下分析CPM的独特作用机制.
- 检查CPM与其他抗癌剂和疗法结合使用的情况.
主要成果:
- 计量学CPM表现出双重活性:高剂量的免疫抑制作用和计量学剂量的免疫活性作用.
- 超过75%的临床研究报告了计量学CPM有希望的结果,特别是在乳腺癌,卵巢癌和前列腺癌中.
- 正在研究各种治疗方法的CPM,包括一线和后一线疗法,通常是组合的.
结论:
- 计量学型环胺利用免疫系统的双重抗瘤作用.
- 这种方法在改善癌症治疗中的疗效/毒性平衡方面显著有前途.
- 需要进一步确认以建立计量学CPM及其类型作为护理标准.
更多相关视频
05:17Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.5K
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
相关概念视频
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:39Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
248
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
248
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
192
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
192